Calne DB - Search Results

1

Transdermal dopaminergic D(2) receptor agonist therapy in Parkinson's disease with N-0923 TDS: a double-blind, placebo-controlled study.

Hutton JT, Metman LV, Chase TN, Juncos JL, Koller WC, Pahwa R, LeWitt PA, Samii A, Tsui JK, Calne DB, Waters CH, Calabrese VP, Bennett JP, Barrett R, Morris JL. Hutton JT, et al. Among authors: calne db. Mov Disord. 2001 May;16(3):459-63. doi: 10.1002/mds.1085. Mov Disord. 2001. PMID: 11391739 Clinical Trial.

2

Levodopa in the treatment of Parkinson's disease: a consensus meeting.

Agid Y, Ahlskog E, Albanese A, Calne D, Chase T, De Yebenes J, Factor S, Fahn S, Gershanik O, Goetz C, Koller W, Kurth M, Lang A, Lees A, Lewitt P, Marsden D, Melamed E, Michel PP, Mizuno Y, Obeso J, Oertel W, Olanow W, Poewe W, Pollak P, Tolosa E, et al. Agid Y, et al. Mov Disord. 1999 Nov;14(6):911-3. doi: 10.1002/1531-8257(199911)14:6<911::aid-mds1001>3.0.co;2-h. Mov Disord. 1999. PMID: 10584663 Review. No abstract available.

3

A double-blind, placebo-controlled, dose-ranging study to investigate the safety and efficacy of CY 208-243 in patients with Parkinson's disease.

Tsui JK, Wolters EC, Peppard RF, Calne DB. Tsui JK, et al. Among authors: calne db. Neurology. 1989 Jun;39(6):856-8. doi: 10.1212/wnl.39.6.856. Neurology. 1989. PMID: 2725884 Clinical Trial.

4

Lisuride treatment in Parkinson's disease: clinical and pharmacokinetic studies.

LeWitt PA, Burns RS, Calne DB. LeWitt PA, et al. Among authors: calne db. Adv Neurol. 1983;37:131-40. Adv Neurol. 1983. PMID: 6344586 Clinical Trial.

5

Recent advances in the treatment of Parkinson's disease: the role of bromocriptine.

Le Witt PA, Calne DB. Le Witt PA, et al. Among authors: calne db. J Neural Transm. 1981;51(1-2):175-84. doi: 10.1007/BF01664014. J Neural Transm. 1981. PMID: 7021769 Clinical Trial.

6

Lisuride versus bromocriptine treatment in Parkinson disease: a double-blind study.

LeWitt PA, Gopinathan G, Ward CD, Sanes JN, Dambrosia JM, Durso R, Calne DB. LeWitt PA, et al. Among authors: calne db. Neurology. 1982 Jan;32(1):69-72. doi: 10.1212/wnl.32.1.69. Neurology. 1982. PMID: 7033825 Clinical Trial.

7

Severity of Parkinson's disease and the dosage of bromocriptine.

Larsen TA, Newman R, LeWitt P, Calne DB. Larsen TA, et al. Among authors: calne db. Neurology. 1984 Jun;34(6):795-7. doi: 10.1212/wnl.34.6.795. Neurology. 1984. PMID: 6539444

8

Individualizing therapy in patients with disabling Parkinson's disease symptoms.

Calne DB, Duvoisin RC, Koller WC. Calne DB, et al. Neurology. 1994 Mar;44(3 Suppl 1):S8-11. Neurology. 1994. PMID: 8121579 No abstract available.

9

Botulinum toxin in the treatment of writer's cramp: a double-blind study.

Tsui JK, Bhatt M, Calne S, Calne DB. Tsui JK, et al. Among authors: calne db, calne s. Neurology. 1993 Jan;43(1):183-5. doi: 10.1212/wnl.43.1_part_1.183. Neurology. 1993. PMID: 8423882 Clinical Trial.

10

The long-term response to levodopa in dopa-responsive dystonia.

Hwang WJ, Calne DB, Tsui JK, de la Fuente-Fernández R. Hwang WJ, et al. Among authors: calne db. Parkinsonism Relat Disord. 2001 Sep;8(1):1-5. doi: 10.1016/s1353-8020(00)00084-5. Parkinsonism Relat Disord. 2001. PMID: 11472874

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

376 results

Search Page